PRA023 SC
/ Merck (MSD)
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
November 23, 2022
Bioavailability of SC Formulation and Japanese Ethnobridging Study for PRA023
(clinicaltrials.gov)
- P1 | N=49 | Completed | Sponsor: Prometheus Biosciences, Inc. | Active, not recruiting ➔ Completed
Trial completion
June 08, 2022
Bioavailability of SC Formulation and Japanese Ethnobridging Study for PRA023
(clinicaltrials.gov)
- P1 | N=49 | Active, not recruiting | Sponsor: Prometheus Biosciences, Inc. | Recruiting ➔ Active, not recruiting
Enrollment closed
April 29, 2022
Bioavailability of SC Formulation and Japanese Ethnobridging Study for PRA023
(clinicaltrials.gov)
- P1 | N=49 | Recruiting | Sponsor: Prometheus Biosciences, Inc.
New P1 trial
1 to 3
Of
3
Go to page
1